title: Decrease in serum IL-32 level in patients with atopic dermatitis after cyclosporine treatment.
authors.affiliation: Department of Dermatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawara, Kyoto, 606-8507, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Kitayama
authors.affiliation: Department of Dermatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawara, Kyoto, 606-8507, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Otsuka
authors.affiliation: Department of Dermatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawara, Kyoto, 606-8507, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Nonomura
authors.affiliation: Department of Dermatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawara, Kyoto, 606-8507, Japan.
authors.forename: C
authors.initials: C
authors.lastname: Nakashima
authors.affiliation: Department of Dermatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawara, Kyoto, 606-8507, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Honda
authors.affiliation: Department of Dermatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawara, Kyoto, 606-8507, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Kabashima
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use*; D003876:Dermatitis, Atopic / Q000097:blood* / Q000188:drug therapy*; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007378:Interleukins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D003879:Dermatologic Agents; C496971:IL32 protein, human; D007378:Interleukins; D016572:Cyclosporine